Singular Genomics Systems Inc (OMIC)
21.90
+0.22
(+1.01%)
USD |
NASDAQ |
Nov 21, 16:00
21.45
-0.45
(-2.05%)
Pre-Market: 20:00
Singular Genomics Systems Enterprise Value: -53.66M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -53.66M |
| November 20, 2024 | -54.21M |
| November 19, 2024 | -54.61M |
| November 18, 2024 | -53.68M |
| November 15, 2024 | -53.66M |
| November 14, 2024 | -51.52M |
| November 13, 2024 | -52.08M |
| November 12, 2024 | -50.97M |
| November 11, 2024 | -51.20M |
| November 08, 2024 | -51.40M |
| November 07, 2024 | -50.14M |
| November 06, 2024 | -52.48M |
| November 05, 2024 | -50.90M |
| November 04, 2024 | -52.63M |
| November 01, 2024 | -74.86M |
| October 31, 2024 | -75.21M |
| October 30, 2024 | -76.07M |
| October 29, 2024 | -74.62M |
| October 28, 2024 | -75.27M |
| October 25, 2024 | -73.57M |
| October 24, 2024 | -74.07M |
| October 23, 2024 | -75.47M |
| October 22, 2024 | -73.22M |
| October 21, 2024 | -70.81M |
| October 18, 2024 | -70.56M |
| Date | Value |
|---|---|
| October 17, 2024 | -70.41M |
| October 16, 2024 | -69.73M |
| October 15, 2024 | -71.46M |
| October 14, 2024 | -71.66M |
| October 11, 2024 | -72.89M |
| October 10, 2024 | -72.79M |
| October 09, 2024 | -70.68M |
| October 08, 2024 | -70.33M |
| October 07, 2024 | -70.73M |
| October 04, 2024 | -74.87M |
| October 03, 2024 | -71.06M |
| October 02, 2024 | -70.11M |
| October 01, 2024 | -70.11M |
| September 30, 2024 | -69.38M |
| September 27, 2024 | -88.19M |
| September 26, 2024 | -88.14M |
| September 25, 2024 | -87.52M |
| September 24, 2024 | -86.29M |
| September 23, 2024 | -86.02M |
| September 20, 2024 | -85.87M |
| September 19, 2024 | -86.37M |
| September 18, 2024 | -84.95M |
| September 17, 2024 | -86.52M |
| September 16, 2024 | -94.88M |
| September 13, 2024 | -95.95M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-169.50M
Minimum
Sep 20 2023
2.212B
Maximum
Jun 01 2021
92.81M
Average
-92.21M
Median
Enterprise Value Benchmarks
| Bruker Corp | 10.71B |
| Azenta Inc | 1.613B |
| Harvard Bioscience Inc | 127.50M |
| Bionano Genomics Inc | 14.35M |
| Akoya Biosciences Inc | 145.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.80M |
| Revenue (Quarterly) | 0.406M |
| Total Expenses (Quarterly) | 18.48M |
| EPS Diluted (Quarterly) | -6.72 |
| Gross Profit Margin (Quarterly) | -74.14% |
| Profit Margin (Quarterly) | -4.14K% |
| Earnings Yield | -158.7% |
| Normalized Earnings Yield | -158.72 |